Home › Brain Diseases › Washington
Brain Diseases clinical trials in Washington
5 studies for Brain Diseases are looking for participants at sites in Washington.
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, Bellevue
RecruitingPhase 2
Ages 55 to 90 · All sexes · Updated Sep 30, 2026 · NCT06887192CoMind Early Feasibility Study
- University of Washington, Harborview, Seattle
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT06368648A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- EvergreenHealth, Kirkland
RecruitingPhase 2
Ages 55 to 85 · All sexes · Updated Sep 22, 2026 · NCT07589595A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
- Vima Site #023, Kirkland
- Vima Site #015, Spokane
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Sep 11, 2026 · NCT07804615North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)
- Seattle Children's Hospital and Regional Medical Center, Seattle
RecruitingObservational studyHealthy volunteers welcome
All ages · All sexes · Updated Feb 4, 2026 · NCT01694940From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.